Wind turbine supplier Suzlon’s initial public offering (IPO) in 2005 was nothing short of stellar. Almost overnight, its founder and chairman, Tulsi Tanti, became one of the richest people in India. At the time, the company was the fifth largest wind energy firm in the world. Two years later, it would establish itself as a major player in the sector, acquiring its German rival REpower for $2 billion (~Rs 13,000 crore). The winds of fortune were blowing in Suzlon’s favour.

Fortune, however, is fickle. Just a year later, Suzlon would begin its rapid descent from the stratosphere to rock bottom.

The company’s aggressive debt-fuelled expansion, which seemed like a smart move before 2008, became a veritable death sentence as the financial crisis sent shockwaves through the global economy. Along with the global financial crisis, Suzlon was also hit with claims that its products were faulty. This caused a sharp drop in both share price and reputation. Its reputation would take a further beating as the company was indicted by Sebi in an insider trading case related to its IPO.

The company’s mounting debts saw it gain infamy in 2012, as it defaulted on $221 million (~Rs 1,480 crore) of foreign currency convertible bonds (FCCBs). This made Suzlon the largest Indian defaulter on foreign currency loans. By this point, the aura of invincibility that Suzlon and Tanti once exuded was now a distant memory.

Since then, the company has repeatedly tried to stage a turnaround, attempting to realise the potential it once seemed so certain to fulfil. However, it’s now a decade since the first cracks appeared in 2008, and this turnaround has repeatedly faltered. Ten years is a long time. Will Suzlon eventually make it as a turnaround story?

One step forward, two steps back

In 2014-15, it seemed like Suzlon was on the road to recovery. The Indian government’s push for more renewable energy, with a target of 60 Gigawatt (GW) from wind energy by 2022, offered the company a massive opportunity.

The company also actively tried to pare its massive debt burden. Suzlon sold Senvion (formerly called REpower) in 2015 for $1.1 billion (~Rs 7300 crore) and used the lion’s share of proceeds to pay off the company’s debts. Ironically, Suzlon had taken on a lot of debt to purchase REpower in the first place. Senvion was Suzlon’s most prized possession, contributing 70% of Suzlon’s overall revenue in FY14. Its sale, however, was not a sign of the company giving up the ghost. Instead, it showed that Suzlon was willing to take hard decisions in order to emerge from the slump it found itself in after 2008.

Around the same time, pharma billionaire Dilip Shanghvi also came on board, buying a 23% stake for Rs 1,800 crore (~$269 million). The entry of Shanghvi, the promoter of Sun Pharma, was greeted with a wave of optimism by both shareholders and analysts.

AUTHOR

Sidhartha Shukla

In his earlier stint at Moneycontrol, the website owned by the Network18 group, Sid wrote on cryptocurrencies, cybersecurity, business, and finance. Born in Raipur, Chhattisgarh, Sid has spent most of his life in Jalandhar, Punjab. He has a BSc in Mathematics from St Xavier’s College, Mumbai. Sid is a comic book nerd and a big fan of Alan Moore, Neil Gaiman and Brian Azzarello. He can be reached at sidhartha at the rate the-ken.com

View Full Profile

Subscribe to read this story

The Ken is the only business subscription you need. Questions?

 

Premium

  • 5 original and reported longform business stories every week
  • Access to ONLY India edition
  • Close to 250 exclusive stories every year
  • Full access to over 5 years of paywalled stories
  • Pick up to 5 premium subscriber newsletters
  • 4 original and reported longform business stories each week
  • Access to ONLY Southeast Asia edition
  • Close to 200 exclusive stories every year
  • Full access to all paywalled stories since March 2020
  • Pick up to 5 premium subscriber newsletters

Rs. 2,750 /year

$ 120 /year

India Edition
Subscribe Subscribe
Most Asked For

Borderless

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 5 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories

Rs. 4,200 /year

Subscribe
 

Echelon

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 5 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories
  • Bonus annual gift subscription
  • Priority access to all new products and features

Rs. 8,474 /year

Subscribe
Or

Questions?

What kind of subscription plans do you offer?

We have three types of subscriptions
- Premium which gives you access to either the India or the Southeast Asia edition.
- Borderless which gives you complete access to The Ken across both editions
- Echelon which gives you complete access to The Ken across both editions along with a bonus gift subscription

What do I get if I subscribe?

The Premium edition gives you access to stories in that edition along with any five subscriber-only newsletters of your choice.

The Borderless and Echelon subscription gives you complete access to The Ken across editions and unlimited access to as many newsletters as you like.

What topics do you usually write about?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics. We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

Our specialised subscriber-only newsletters are written by our expert, award-winning journalists and cover a range of topics across finance, retail, clean energy, cryptocurrency, ed-tech and many more.

How many newsletters do you have?

We are constantly adding specialised subscriber-only newsletters all the time. All of these are written by our team of award-winning journalists on a specialised topic.

You can see the list of newsletters that we publish over here.

Does a Premium subscription to your Indian edition get me access to the Southeast Asia edition? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

We recommend the Borderless or the Echelon Plan which will give you access to stories across both editions.

Do you have a mobile app?

Yes! We have a top-rated mobile app on both iOS and Android which allows you to read on-the-go and has some amazing features like the ability to bookmark stories, save on your device, dark mode, and much more. It’s really the best way to read The Ken.

Is there a free trial?

You can sign up for a free account to experience The Ken and understand our products better. We’ll send you some free stories and newsletters occasionally, and you can access our archive of previously published free stories. You can stay on the free account as long as you’d like.

The vast majority of our stories, articles and newsletters can be accessed only by a paid subscription.

Do you offer any discounts?

Sorry, no. Our journalism is funded completely by our subscribers. We believe that quality journalism comes at a price, and readers trust and pay us so that we can remain independent.

Do you offer refunds?

No. We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Just write to us at [email protected] with details. We’ll help you out.

I have a few more questions. How can I reach out to you?

Sure. Just email us at [email protected] or follow us on Twitter.